Related Experiment Video
Updated: Sep 6, 2025
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
Multi-block data integration analysis for identifying and validating targeted N-glycans as biomarkers for type II
Eric Adua1,2, Ebenezer Afrifa-Yamoah3, Emmanuel Peprah-Yamoah4
1Rural Clinical School, Medicine and Health, University of New South Wales, Sydney, NSW, Australia. e.adua@unsw.edu.au.
Abstract:
Plasma N-glycan profiles have been shown to be defective in type II diabetes Mellitus (T2DM) and holds a promise to discovering biomarkers. The study comprised 232 T2DM patients and 219 healthy individuals. N-glycans were analysed by high-performance liquid chromatography. The multivariate integrative framework, DIABLO was employed for the statistical analysis. N-glycan groups (GPs 34, 32, 26, 31, 36 and 30) were significantly expressed in T2DM in component 1 and GPs 38 and 20 were related to T2DM in component 2. Four clusters were observed based on the correlation of the expressive signatures of the 39 N-glycans across T2DM and controls. Cluster A, B, C and D had 16, 16, 4 and 3 N-glycans respectively, of which 11, 8, 1 and 1 were found to express differently between controls and T2DM in a univariate analysis [Formula: see text]. Multi-block analysis revealed that trigalactosylated (G3), triantennary (TRIA), high branching (HB) and trisialylated (S3) expressed significantly highly in T2DM than healthy controls. A bipartite relevance network revealed that HB, monogalactosylated (G1) and G3 were central in the network and observed more connections, highlighting their importance in discriminating between T2DM and healthy controls. Investigation of these N-glycans can enhance the understanding of T2DM.
